Canbridge Pharmaceuticals Inc
HKEX:1228
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Canbridge Pharmaceuticals Inc
HKEX:1228
|
CN |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
MIL:FILA
|
IT |
|
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
|
FR |
|
O
|
Octodec Investments Ltd
JSE:OCT
|
ZA |
|
P
|
Paysauce Ltd
NZX:PYS
|
NZ |
|
Alterola Biotech Inc
OTC:ABTI
|
US |
|
C
|
Cab Payments Holdings PLC
LSE:CABP
|
UK |
|
Mirait One Corp
F:5FO
|
JP |
|
A
|
Alligo AB
STO:ALLIGO B
|
SE |
|
Aaron's Company Inc
NYSE:AAN
|
US |
|
P
|
Procook Group PLC
LSE:PROC
|
UK |
|
Cambium Networks Corp
NASDAQ:CMBM
|
US |
|
P
|
Polygon Real Estate Ltd
TASE:POLY
|
IL |
|
S
|
SIK Cheong Bhd
KLSE:SCB
|
MY |
|
GE Vernova Inc
MIL:1GEV
|
US |
Bankruptcy Probability
Canbridge Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Canbridge Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Canbridge Pharmaceuticals Inc
HKEX:1228
|
1.3B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Canbridge Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Canbridge Pharmaceuticals Inc has total debt of 8.4m CNY. This includes both short-term (0 CNY) and long-term (8.4m CNY) debt.
You can find a full breakdown on its Balance Sheet.
